Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Renal Neoplasms With Perfusion Magnetic Resonance Imaging

NCT02526511 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT02526511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02526511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Renal Neoplasms With Perfusion Magnetic Resonance Imaging
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
September 30, 2023
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage i renal cell cancer, stage ii renal cell cancer, stage iii renal cell cancer, stage iv renal cell cancer